Dose Escalation in Patients With Crohn's Disease Who Are Newly Initiated to Therapy With an Anti-TNF

被引：0
|
作者：
Kane, Sunanda [1 ]
Horst, Sara [2 ]
Beaulieu, Dawn [2 ]
Schwartz, David [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
INFLAMMATORY BOWEL DISEASES | 2012年 / 18卷
关键词：
D O I：
10.1097/00054725-201212001-00088
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [1] Corticosteroid Avoidance in Patients with Crohn's Disease Who Are Newly Initiated to Therapy with an Anti-TNF Versus Azathioprine
    Kane, Sunanda
    Schwartz, David
    Jaganathan, Srihari
    Jenkins, Sunshine
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S648 - S648
  • [2] Rate of Ustekinumab Dose Escalation in Patients With Crohn's Disease Who Had a History of Anti-TNF Dose Escalation
    Sun, Kelly
    Manski, Scott
    Crawford, Albert
    Shivashankar, Raina
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S5 - S5
  • [3] Corticosteroid avoidance in patients with crohn's disease who are newly initiated to therapy with an anti-TNF agent versus azathioprine
    Kane, Sunanda
    Hassig, Tanna
    Malpas, Phyllis
    Pennington, KellyAnne
    Smith, Teak
    Hicks, Rachel Velvet
    Dowdle, Merriman
    Jaganathan, Srihari
    Horst, Sara
    Schwartz, David A.
    [J]. PHARMACOTHERAPY, 2013, 33 (10): : E253 - E253
  • [4] Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease
    Rubin, David T.
    Kane, Sunanda
    Jaganathan, Srihari
    Palmer, Liisa
    Cyhaniuk, Anissa
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (05) : E135 - E140
  • [5] Anti-TNF Therapy for Crohn's Disease: Predictors of Dose Escalation and Early Discontinuation By 1 Year of Therapy
    Naik, Amar S.
    Qumseya, Bashar
    Ananthakrishnan, Ashwin N.
    Zadvornova, Yelena
    Skaros, Susan
    Beaulieu, Dawn B.
    Johnson, Kathryn
    Perera, Lilani P.
    Binion, David G.
    Issa, Mazen
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A654 - A654
  • [6] Anti-TNF Therapy in Crohn's Disease
    Adegbola, Samuel O.
    Sahnan, Kapil
    Warusavitarne, Janindra
    Hart, Ailsa
    Tozer, Philip
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [7] Anti-TNF therapy and Crohn's disease
    Peyrin-Biroulet, L.
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 478 - 481
  • [8] Another anti-TNF therapy for patients with Crohn's disease
    Cross, Raymond
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (03) : 425 - 427
  • [9] Anti-TNF therapy for Crohn's disease
    D'Haens, G
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (04) : 289 - 294
  • [10] Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation
    Viazis, Nikos
    Koukouratos, Theodoros
    Anastasiou, Jiannis
    Giakoumis, Marios
    Triantos, Christos
    Tsolias, Chrisostomos
    Theocharis, Georgios
    Karamanolis, Dimitrios G.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (04) : 436 - 441
12345